Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant

NCT06734585 · clinicaltrials.gov ↗

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Gilteritinib

Sponsor

Astellas Pharma Singapore Pte. Ltd.